Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ESC 2026 28 - 31 August 2026

Breaking boundaries in cardiometabolic care with oral and injectable GLP-1RAs

Add to Calendar
Download agenda
Saturday, 29 August 2026
12:30 - 12:35
(CEST)

Welcome & introduction

Erin Bohula
12:35 - 12:47
(CEST)

CV outcomes with GLP-1RAs: Evidence beyond a class effect

Subodh Verma
12:47 - 12:59
(CEST)

Oral and injectable GLP-1RAs: A new chapter in CV therapies

Domenica Rubino
12:59 - 13:05
(CEST)

GLP-1RAs in clinical CV guidelines: The latest insights

Erin Bohula
13:05 - 13:23
(CEST)

Where evidence meets practice: Clinical considerations with GLP-1RAs

Erin Bohula, Subodh Verma, Domenica Rubino
13:23 - 13:28
(CEST)

Q&A

Erin Bohula, Subodh Verma, Domenica Rubino
13:28 - 13:30
(CEST)

Closing

Erin Bohula
Keywords
Cardiovascular Disease
Congress industry session
GLP-1 RA
Semaglutide